v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities    
Net income $ 72,862 $ 62,148
Loss from discontinued operations, net of taxes 0 34,920
Income from continuing operations 72,862 97,068
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations:    
Depreciation and amortization 55,769 54,777
Long-Lived Asset, Held and Used, Impairment Loss 1,134 182
Net gain on sale of assets (1,353) (13,124)
Net gain on sale of businesses (1,164) (409)
Unrealized Gain (Loss) on Investments (9,759) 26,036
Stock-based compensation expense 3,262 3,185
Equity method earnings (10,656) (16,793)
Noncash debt refinancing expenses 0 1,921
Amortization of debt discounts and debt issuance costs 1,566 2,654
Deferred tax benefit (3,161) (2,831)
Pension and other postretirement benefit plan cost 4,621 2,868
Dividends received from equity method investments 6,596 6,268
Insured Event, Gain (Loss) 0 (3,869)
Other 0 (1,565)
Changes in operating assets and liabilities:    
Receivables, net of allowances (132,369) (211,944)
Inventories 81,227 25,736
Prepaids, other current assets and other assets (27,508) (12,816)
Accounts payable, accrued liabilities and other liabilities (49,570) (17,790)
Net cash used in operating activities - continuing operations (8,503) (60,446)
Investing activities    
Sales of assets 7,465 10,076
Capital expenditures (42,545) (72,196)
Proceeds from sale of businesses, net of transaction costs and cash transferred 4,968 409
Insurance proceeds 0 18,971
Net sales (purchases) of unconsolidated affiliates 231 (1,589)
Payments to Acquire Additional Interest in Subsidiaries 51,193  
Payments to Acquire Businesses, Net of Cash Acquired 2,303 1,882
Other (439) (14)
Net cash used in investing activities - continuing operations (83,816) (46,225)
Financing activities    
Proceeds from borrowings and overdrafts 1,068,317 1,151,108
Repayments on borrowings and overdrafts (901,189) (1,002,113)
Dividends paid to shareholders (16,701) (15,934)
Dividends paid to noncontrolling interests (7,192) (7,962)
Payments for Repurchase of Common Stock (14,644) 0
Payment, Tax Withholding, Share-Based Payment Arrangement (3,378) 0
Proceeds from (Payments to) Noncontrolling Interests 3,411 0
Payment of contingent consideration (2,305) (919)
Net cash provided by financing activities - continuing operations 119,497 124,180
Effect of foreign exchange rate changes on cash (3,327) 18,859
Net cash used in operating activities - discontinued operations 0 (23,870)
Net cash used in investing activities - discontinued operations 0 (4,850)
Cash used in discontinued operations, net 0 (28,720)
Increase in cash and cash equivalents 23,851 7,648
Cash and cash equivalents at beginning of period, including discontinued operations 267,854 331,719
Cash and cash equivalents at end of period, including discontinued operations 291,705 339,367
Income tax payments, net of refunds (40,822) (53,567)
Interest payments on borrowings $ (25,422) $ (32,119)